Skip to main content

India is 4th largest medical devices market in Asia after Japan, China, and South Korea

 

Life Sciences are a category encompassing the wide range of industries related to biological sciences. By and large this industry is related to human healthcare, including pharmaceuticals, diagnosis, healthcare facilities, medical devices and policy making. 

THE PHARMA STORY IN INDIA 

The Indian pharmaceutical industry’s year-on-year revenue growth is back on track, as per top healthcare consulting firms in India. While the global pharmaceutical market stood at $934.8 billion in 2017 and will reach $1.17 trillion in 2021, the domestic industry was estimated at $33 billion in the same year. 

India is the largest provider of generic drugs globally and caters to over 50% of global demand for various vaccines, 40% of generic demand in the U.S., and 25% of all medicines in the U.K. 


OVERVIEW OF THE MEDICAL DEVICES INDUSTRY IN INDIA 
 
The Medical Devices industry in India is presently valued at USD 5.2 billion and contributes 4-5% to the USD 96.7 billion Indian health care industry. Consulting firms in India have cited the following statistics that put India high up on the global map. 

  • The industry has steadily grown and witnessed a surge from USD 2.02 billion in 2009 to USD 3.9 billion in 2015 at a CAGR of 15.8% 
  • As per industry estimates, the Indian medical devices market will grow to USD 50 billion by 2025 
  • Currently, India is counted among the top 20 global medical devices market  
  • India is the 4th largest medical devices market in Asia after Japan, China and South Korea 
  • The estimated market size of the consumer and durable segment is USD 1404 million 



HEALTHCARE IN INDIA 

Ayushman Bharat is the largest government funded healthcare program in the world. Technology is playing a key role of equaliser in taking preventive healthcare to second and third wave of demography across geography and class.  


Road Ahead for Healthcare  

  • By 2020, the healthcare information technology market is expected to grow 1.5 times from current $1 bn 
  • By 2022, the diagnostics market is expected to grow at a CAGR of 20.4% to reach $ 32 bn from $ 5 bn in 2012 
  • 100% FDI is allowed under the automatic route of greenfield projects 
  • For investments in brownfield projects upto 100% FDI is permitted under the government route 


FOREGIN COMPANIES COULD LOOK TO INVEST IN THESE SEGMENTS IN INDIA 

Hospitals 

There is tremendous demand for tertiary care hospitals and specialty hospitals in IndiaMost healthcare players have been setting up additional facilities to cater to critical care or super-speciality healthcare and some leading hospital players are aggressively raising funds for theirRecently, Fortis Healthcare Ltd. accepted the proposal from Malaysia’s IHH Healthcare Berhad to invest INR 4,000 crores in the Indian Hospital Chain. 

MEDICAL DEVICES AND EQUIPMENTS 

Investment in the medical equipment-manufacturing sector is one of the most attractive areas for foreign companies. This sector has seen a significant flow of foreign investments over the past few years. Business consultancy services in India have given a thumbs up to the medical equipment manufacturing industry which is expected to grow in tandem with the hospital sector, touching nearly USD 60 billion 


DIAGNOSTICS 

Diagnostic centres are proving to be a lucrative business/investment opportunity for foreign companies. These centres have expanded their service to include all kinds of diagnostic services including cardiology and neurology. 


TECHNOLOGY DRIVEN SERVICES 

Tele-medicine and e-Healthcare and Tele-radiology have emerged very fast with an increasing number of foreign hospitals active in this space. Many hospitals have adopted the foreign partnership route to render these services. 


HEALTH INSURANCE 

The domestic health insurance business at INR 12,606 crore (USD 2.03 billion), accounts for about a quarter of the total non-life insurance business in the country. New products that also cover certain ailments not covered earlier are seeing more buyers of such insurance policies. 


SOME SUCCESSFUL MNC INVESTMENTS IN INDIA 

ABBOTT 

US-based global healthcare and research company Abbott Laboratories has a strong presence in therapeutic, Gastroenterology, Diabetes and women’s health category in India. 

GLAXOSMITHKLINE 

GlaxoSmithKline is one of the world’s top research-based health management and pharmaceutical companies in India. It’s market capitalisation stood at Rs. 27,522.55 crore on June 2015. 


ADVANTAGE INDIA 

  • 100% FDI in health 
  • Large domestic market  
  • Rising affordability 
  • Availability of skilled and qualified Human Resources 
  • Enabling environment – growing GDP and FDI 

Website: www.tecnovaglobal.com 

Comments

Popular posts from this blog

Pharmaceutical and Healthcare Consulting Services for German Companies for Indian Market

For Germany Companies, German manufacturer-Retailer-Franchise - Market Research India, Healthcare Consulting - Healthcare & Pharma Regulatory Consulting Firms in India PHARMACEUTICALS & HEALTHCARE CONSULTING | pharma consulting companies in india | pharmaceutical consulting india| Pharmaceutical Regulatory Consulting Firms in India|top pharmaceutical consulting firms in india|Healthcare & Pharma Regulatory Consulting Firms in India Regulatory Affairs: Pharmaceutical and healthcare consulting firms can help German companies navigate the complex regulatory landscape in India. This includes obtaining necessary licenses, approvals, and registrations with Indian regulatory authorities such as the Central Drugs Standard Control Organization (CDSCO). Market Research : Pharmaceutical and healthcare consulting firms can conduct comprehensive market research to help German companies understand the Indian healthcare market. This includes analyzing market trends, identifying potent...

How Indian Sourcing Can Be Beneficial for Foreign Companies.

In today's globalized economy, businesses are constantly seeking new avenues for sourcing products and services to remain competitive. How Sourcing from India Can Benefit Foreign Businesses Why is Sourcing from India Beneficial for Foreign Companies? Foreign organizations can get multiple benefits by  sourcing from the Indian market . Some of them are as follows: Cost-Effectiveness Skilled Workforce Wide Range of Products and Services Robust Manufacturing Infrastructure Access to a Growing Consumer Market Favorable Government Policies Cultural and Geographical Advantage

Bright days ahead for India: Unmatched ROI 2021 from Emerging Indian Market 2021

AN UNMATCHED ROI POOL FROM THE EMERGING INDIAN MARKET IN 2021. India has been one of the fastest-growing Asian economies in the world over the last few years. Some of the major stimuli to this growth are the rising demands of a large consumer base and significant development of the IT and manufacturing sectors. Most attractive: Indian Emerging Market Factors that are promoting this accelerated growth of the Indian Emerging Market Here are some of the essential factors contributing to India’s competitiveness and scope for an unmatched ROI pool. Geographic advantages Strong support of Infrastructure Expected infrastructure development Low-cost skilled labor Suppliers of Raw Materials Impressive logistics capabilities Favorable Government Initiatives Product Linked Incentive Scheme (PLI) 100% Foreign Direct Investments Tecnova, one of the  leading business setup consultants in India , offers you personalized India market entry consulting services which include: Structuring a corporate...